In keeping with recent in situ expression studies in patients with COPD,14 we found that basal expression of ACE2 was increased by approximately 3-fold in BECs from patients with COPD compared with in healthy nonsmokers (Fig 5, B). Here, ACE2 is linked to chronic obstructive pulmonary disease.